for Aug 29, 2020 through Sep 04, 2020
The coronavirus advisors Trump is surrounding himself with? One who has been called the “anti-Dr. Fauci” doesn’t have a background in infectious diseases or epidemiology.
— Kamala Harris (@KamalaHarris) September 1, 2020
We need new leadership. Lives depend on it. https://t.co/fYdfFJrxCi
"Atlas, who does not have a background in infectious diseases or epidemiology, has expanded his influence inside the White House by advocating policies that appeal to Trump’s desire to move past the pandemic "https://t.co/jIwRwxEBKb
— Rachel Maddow MSNBC (@maddow) August 31, 2020
REMDESIVIR, NO EFFECT. I’m disappointed for patients. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial | Infectious Diseases | JAMA | JAMA Network https://t.co/mSk89nyag0
— Dr. Urso (@richardursomd) September 4, 2020
“If it hadn’t been for the COVID virus infection, these people would be living today,” an infectious diseases expert said. “So yes, although they have contributing underlying chronic health factors, it’s still the COVID virus that killed them.” https://t.co/2AhrZWHjFe
— WFLA NEWS (@WFLA) September 1, 2020
New White House pandemic adviser "does not have a background in infectious diseases or epidemiology" but "has expanded his influence inside the White House by advocating policies that appeal to Trump’s desire to move past the pandemic." https://t.co/N3MKwXdOHM
— Michael Calderone (@mlcalderone) August 31, 2020
Thanks to former super ID Fellow, Dr. Fernando Dominguez (who has recently joined Twitter, follow him at: @FDominguezID) for pointing out 6 RCTs on shorter Abx for acute bacterial sinustis. Updated Table is below, and with references on website: https://t.co/GTEBUJEUYn pic.twitter.com/Hq2sgGmZg8
— Brad Spellberg (@BradSpellberg) September 1, 2020
COVID-19 may not be characterized by cytokine storm🤔@JAMA_current study,critically ill patients with #COVID19 w ARDS had circulating cytokine levels that were lower compared with patients with bacterial sepsis & similar to other critically ill patients.https://t.co/EGOiYki6t9 https://t.co/wBX3u6iEGQ pic.twitter.com/J8yqf4PFcF
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 3, 2020
There is now gender parity at the med student level but #WomenInMedicine remain underrepresented in the higher ranks of academic medicine and healthcare. The time is NOW to end this with men working side-by-side with women for gender equity. #HerTimeIsNow https://t.co/GMJXIV46MX pic.twitter.com/It1xEU9njX
— Carlos del Rio (@CarlosdelRio7) September 1, 2020
Scott Atlas, Trump's New Virus Adviser, Questioned Mask Use https://t.co/usFcfWROgl
— Errington Thompson, MD (@ecthompsonmd) September 2, 2020
I don't understand where this guy came from. Oh, wait. Fox News. He has no training in epidemiology or infectious diseases. He is a neuroradiologist.
Excellent @TIME article by Professor Jimenez @jljcolorado compelling case for using masks in all risky settings and explains mystery of why so many infectious diseases specialists adamantly opposed (Hint: They were taught that way) https://t.co/4YTOfnezBO
— Bill Bowtell AO (@billbowtell) August 29, 2020
Unbelievable🤬
— 17grasshopper17 (@grasshopperxcc) September 3, 2020
Greece announces up to life in prison for violating coronavirus quarantine rules
Strict penalties for those who violate the penal provisions for the spread of infectious diseases are now being enforced, and violators could spend up to life!https://t.co/cH4W8AVPk0
🔥PUBLISHED 🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 2, 2020
A meta-analysis pooling 7 RCTs
Association Between Systemic Corticosteroids & Mortality Among Critically Ill Pts With COVID-19
systemic corticosteroids was associated with ⬇️ 28-day all-cause mortality in critically ill pts https://t.co/CWm3tsWmFT @JAMA_current pic.twitter.com/jdLGpGBjP0
🔥COALITION II RCT PUBLISHED🔥 @TheLancet
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 4, 2020
Open label 447 🇧🇷
In patients with severe #COVID19 , adding azithromycin to standard of care treatment (which included hydroxychloroquine) did NOT improve clinical Outcomes. https://t.co/hzvncvlAEH pic.twitter.com/mzvHmeWIXD
"Atlas, who does not have a background in infectious diseases or epidemiology, has expanded his influence inside the White House by advocating policies that appeal to Trump’s desire to move past the pandemic"https://t.co/6W4EeC000j
— Michelle Goldberg (@michelleinbklyn) August 31, 2020
Scott Atlas promotes "herd immunity" to combat the coronavirus. Why is a doctor who does not have a background in infectious diseases or epidemiology on the team? He's telling Trump what he wants to hear, calling himself the "anti-Dr. Fauci."https://t.co/z8T8UlxK4B
— 𝐃𝐞𝐦𝐚𝐧𝐝 𝐓𝐡𝐞 𝐓𝐫𝐮𝐭𝐡 (@essenviews) August 31, 2020
“Vaccines can end pandemics but also pandemics can end vaccines” said @ASlavitt We should remember what happened last time we rushed a vaccine @NYTOpinion https://t.co/UylELVZFpo
— Carlos del Rio (@CarlosdelRio7) September 3, 2020
Fauci's remarks come amid Trump’s elevation of a new health adviser, Dr. Scott Atlas.
— POLITICO (@politico) September 2, 2020
A physician with no expertise in infectious diseases, Atlas is known for his rosier assessments of the pandemic and his resistance to #Covid-related restrictions https://t.co/K05Il3EIQQ
Probable Evidence of Fecal Aerosol Transmission of #SARSCoV2 in a High-Rise Building | @AnnalsofIM https://t.co/WOazcomqpe "On the basis of circumstantial evidence, fecal aerosol transmission may have caused the community outbreak of COVID-19 in this high-rise building"
— Carlos del Rio (@CarlosdelRio7) September 1, 2020
New research Article @TheLancet: Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe #COVID19 in Brazil (COALITION II): a randomised clinical trial https://t.co/X2uhWj0MLa
— The Lancet Infectious Diseases (@TheLancetInfDis) September 4, 2020
Model projections are used again to scare people into wearing masks despite the total lack of scientific evidence that cloth masks have any effect on reducing viral infectious diseases: https://t.co/MbyDPaNtqU
— Ned Nikolov, Ph.D. (@NikolovScience) September 4, 2020
COVID Task Force pushes for mandatory masks based on INFLATED data!
New Trump coronavirus adviser Scott Atlas pushes controversial 'herd immunity' strategy - This is would be a disaster. Best case scenario we maintain current levels of infection until vaccine available. That means ~ 120,000 deaths between now and Dec 31. https://t.co/zNrndjESjv
— Carlos del Rio (@CarlosdelRio7) August 31, 2020
Adult TB meningitis meta-analysis, EBV and bronchiectasis exacerbations, LVAD infections, OPAT during COVID19, mortality with HIV in Haiti, non-FQ options for M genitalium, and other interesting ID papers in the August issue of OFID. Read more here! https://t.co/0oU4iaVP2i pic.twitter.com/ilkpPgmt1e
— Paul Sax (@PaulSaxMD) September 3, 2020
Public health used to be about fighting infectious diseases. But long ago the public-health set grew tired of that tedious business and began lecturing us about inequality and eating too much chocolate. No wonder they fluffed this pandemic, says @cjsnowdonhttps://t.co/Z1TmaRwYnZ
— spiked (@spikedonline) September 4, 2020
🌟β-lactam Dosing Strategies: Think before You Push.🌟
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) August 31, 2020
Simulations demonstrated that IV Push cefepime resulted in lower PTAs than traditional intermittent infusion among a subset of elevated MICs. #IDTwitter #IJAA https://t.co/fuNkZkybxH
New review in #MMBRJournal: Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies https://t.co/vlYuuUisHp pic.twitter.com/gVIk6Vy11P
— ASM (@ASMicrobiology) September 1, 2020
In addition to nitrogen fixation, legume root nodules are likely also sites of active antimicrobial production. @mBioJournal https://t.co/pGi7qYHvaH pic.twitter.com/zpvzwsMQHh
— ASM (@ASMicrobiology) August 31, 2020
"The excessive use of azithromycin is going to lead to widespread azithromycin resistance…you remove azithromycin, what do you have left?"
— IDSA (@IDSAInfo) August 31, 2020
Former IDSA President Dr. Calvin Kunin, FIDSA urges doctors to stop over-prescribing antibiotics during COVID-19. https://t.co/r9TcBMOKAs
ICYMI
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) August 31, 2020
🌟When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit.🌟 #CMI
The 1 million 💰 Q: Can we afford to ‘watch and wait’ for infection in an ICU patient?! #IDTwitter https://t.co/2cSACGKe05 pic.twitter.com/awWqiCsDlP
🔥Interesting🔥 #JACnews @BSACandJAC
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) August 31, 2020
A Multicentre,prospective observational 🇬🇷 study septic pts documented infections(n: 262)to assess the feasibility &the impact of antimicrobial de-escalation in ICUs w high rates of antimicrobial resistance #IDTwitter https://t.co/LIxw5kzfI6
🔥Interesting🔥 @PharmacoJournal @KellyReveles
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 1, 2020
National Trends in Oral Antibiotic Prescribing in US Physician Offices 2009-2016
No significant ⬇️ in outpatient Abx prescribing
>50% of ABx inappropriate
The most common Abx class was❓🤔#IDtwitter https://t.co/JjH5oMmXAY
🔥Sanofi announced that the global Phase 3 trial RCT "420 Pts" IV Kevzara® (sarilumab) at a dose of 200 mg or 400 mg in severely or critically ill hospitalized #COVID19 pts did NOT meet its primary endpoint and key secondary endpoint vs placebo.🔥https://t.co/MvXAUMqocY
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 1, 2020
In vivo pharmacodynamics of new-generation β-lactamase inhibitor taniborbactam in combination with cefepime against serine-β-lactamase-producing Gram-negative bacteria. #JACnews #IDTwitter @BSACandJAC
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) August 30, 2020
Dr Nicolau https://t.co/9hHvqr1Amq https://t.co/lPN1SrYGwY
This week seemed to be the week of reinfections in #Covid19 world. It started with a report that Hong Kong had seen a reinfection 4.5 months after the original.
— Helen Branswell (@HelenBranswell) August 29, 2020
That paper is out in Clinical Infectious Diseases: https://t.co/VklNLO5XM6
Ciao!
— Stan Deresinski (@StanDeresinski) August 29, 2020
Our online WHO antimicrobial stewardship course now available in Italian - Russian & Spanish next. https://t.co/f38SjATS64
Yesterday I discussed the importance of vaccination for safe, effective and long lasting control of infectious diseases, including #COVID19 control. If you didn’t get a chance to watch the live media event, read online here:https://t.co/TFtEMWt7aa
— Dr. Theresa Tam (@CPHO_Canada) September 2, 2020
⛔Preprint⛔
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 2, 2020
🔥#COVACTA PUBLISHED🔥
Tocilizumab in Hospitalized Patients With #COVID19 Pneumoniahttps://t.co/0Km1cgAH9H@IDstewardship @jesusrbano https://t.co/uuD93AbhUJ
Our paper is out in a special #JID supplement on infectious diseases and injection drug use! We used telehealth to successfully treat #HepatitisC in a high-risk population and build the HCV workforce in a #rural region. #OpenAccess article here: (1/n)https://t.co/uBDr4xpVwo
— Jackie Sherbuk (@jsherbuk_md) September 3, 2020
Reinfection with SARS-CoV-2 -- sometimes with severe disease -- may be discouraging, but there's still *a lot* we don't know. (Current count is 8, undoubtedly more to come.) Some thoughts here: https://t.co/TW4K8pEkjO
— Paul Sax (@PaulSaxMD) August 31, 2020
Children can carry Covid-19 virus in their respiratory tracts for weeks, study finds | @Health24com https://t.co/JAfUmsT1JE pic.twitter.com/Qai6oM7R4g
— News24 (@News24) September 1, 2020
Scientists develop lysin-based antibacterial agent that may enable safe repeated dosing to treat life-threatening infections by #MRSA & other types of S. aureus.
— Microbes&Infection (@MicrobesInfect) September 3, 2020
Lysins are promising next-generation antibiotics & kill drug-sensitive & -resistant bacteriahttps://t.co/740tKCNRCK
Early on, the WH coronavirus task force recommended surveillance testing to identify asymptomatic cases. They’ve given no good reason to change that.
— Rep. Ted Deutch (@RepTedDeutch) August 31, 2020
Dr. Atlas isn’t an expert in infectious diseases. He’s an expert in saying what Trump wants to hear.
https://t.co/e7ICZfDI3H
“Journal club. Two of the most feared words in pharmacy school,” wrote HSC student pharmacist, Benjamin Gal. Based on his experience during an APPE rotation, he shared five tips to help other students in @IDstewardship.
— HSC College of Pharmacy (@UNTSCP) September 1, 2020
https://t.co/7qDKHH7uJ5 #HSCproud #pharmacists
Professor @Alison_Galvani has used her modelling skills to address Ebola, flu, HIV, health-care reform, and now COVID-19.
— Yale School of Public Health (@YaleSPH) August 31, 2020
“Alison Galvani is an international star in the field of modelling of infectious diseases”, says Anthony Fauci in @TheLancet. @YCIDMAhttps://t.co/5yKU8ZiDXS
Nicely done cohort study from Montreal showing that suppressed patients with likely NRTI resistance on a boosted PI plus NRTIs can safely switch to DTG-based regimens.https://t.co/UZ7aw71rEs
— Paul Sax (@PaulSaxMD) September 4, 2020
🔥Interesting study #CID 🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 4, 2020
Normal serial CRP and PCT measurements within 36 hours after the start of empiric antibiotic therapy can exclude the presence of neonatal early-onset sepsis with a high probability. #IDTwitter https://t.co/ILwizrjRZC
One third have evidence of myocarditis. Seems prudent to learn more and not push ahead with football risking the lives of unpaid athletes https://t.co/oEe7zWjESa
— 𝙀𝙡𝙞 𝙋𝙚𝙧𝙚𝙣𝙘𝙚𝙫𝙞𝙘𝙝 🤚 🧼😷 (@eliowa) September 3, 2020
135 CC adults pts were screened 14.1% aspergillosis
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) August 29, 2020
12·6% yeast infections
The overall mortality 38%
53% & 31% in patients with &without fungal disease, respectively
mortality rate was ⬇️ by antifungal The use of steroids ⬆️ the likelihood of aspergillosis https://t.co/AyVUh6qn02
Excellent article on the mounting evidence for relationship between #SARSCoV2 viral load and clinical outcome, suggesting less (interaction time) is more https://t.co/AVvhVzUIpS
— Marc Mendelson (@SouthAfricanASP) September 4, 2020
Please RT! @Dani6020 and my lab are looking to fill a Postdoctoral position to study T cell responses against emerging viral infections @ljiresearch. If you love T cells as much as we do, apply here https://t.co/qEFlKar9J0
— Alessandro Sette (@SetteLab) September 2, 2020
Special issue:
— Microbes&Infection (@MicrobesInfect) September 3, 2020
Highly Pathogenic Microbes Causing Respiratory Infection.
As we begin #fluseason while still grappling with #coronavirus pandemic, timely reviews on different respiratory infections https://t.co/oONwqWZZXN #flu #influenza pic.twitter.com/76Eh0c3oZb
I like free stuff, especially free articles about ABX stewardship in CID! https://t.co/fhpkGW03wV editorial with @glavaidguy and Dr. Furukawa :-) #IDtwitter
— Bug Pharmacist 💊🧫 Tim Gauthier (@IDstewardship) September 1, 2020
Antibacterials do not treat viruses.
Created by Cameron Forbes. Last updated September 19, 2020 at 05:08 EST.